AARD · NASDAQ · Biotechnology

Aardvark Therapeutics (AARD)

Develops gut-restricted oral programs for hunger-associated conditions and obesity.

$5.75
After-hours close+0.05 (+0.88%)
At close$5.70(+2.33%)